Alfred Sandrock, Group SVP, Chief Medical Officer at BIOGEN IDEC INC. (BIIB), sold 6,000 shares at $406.40 ($2.5M) on 2015-03-02, disclosed to the SEC on 2015-03-03.
Scheduled sale ($2.5M) by Group SVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $409.59 | 2,826 | $1.2M | 47.1% |
| 2 | $406.40 | 100 | $41K | 1.7% |
| 3 | $407.95 | 1,100 | $449K | 18.3% |
| 4 | $408.98 | 600 | $245K | 10.0% |
| 5 | $410.57 | 374 | $154K | 6.2% |
| 6 | $411.39 | 1,000 |
| $411K |
| 16.7% |
| Total | $409.54 avg | 6,000 | $2.5M | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |